Trial intelligence / Profile preview

Butorphanol vs Fentanyl for Hospital-Acquired Infections in Mechanically Ventilated Patients

NCT05201560Unknown

Sponsor
Zhongshan Hospital, Fudan University
Start
Jan 2022
Primary completion
Jan 2023
Modality
Small Molecules
01

Overview

Randomised trial of butorphanol in Hospital-Acquired Infection (HAI) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Incidence of hospital-acquired infections at 1 month. Status: unknown.

02

Drugs

butorphanol
03

Conditions

Hospital-Acquired Infection (HAI)

Beyond the preview

Go deeper on NCT05201560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05201560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call